In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity 2021 Conference, about The Semaglutide Treatment Effect in People with Obesity (STEP) Trials. Topics covered include the results of the four STEP trails, obstacles to treating obesity, new obesity treatments in the pipeline, and the opportunities for increasing obesity education for future clinicians.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.
Episode Guest
Nicholas Pennings, DO, FOMA, Dipl. ABOM
Resources Mentioned
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC and Sarah Wells, MD discuss a recent article about...
In this episode, obesity medicine specialist and OMA clinical education director, Dr. Nicholas Pennings interviews Gary Taubes, keynote speaker from Obesity Medicine 2021 –...
Episode Description In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM and Sara Karjoo, MD, Dipl. ABOM review the article...